Cite

HARVARD Citation

    Waiser, J. et al. (2016). Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection. Transplantation direct. 2 (8), p. . [Online]. 
  
Back to record